Autoimmune hepatitis (AIH) is an inflammatory disease of the liver that results in immune mediated destruction of liver cells that can result in cirrhosis, liver failure, and even death. AIH can present as an acute fulminant event or insidiously over many years, however diagnosis and treatment implementation can be delayed because of complex clinical presentations. Epidemiologic reports have solidified the observation of a female predominance, yet AIH can present in all ages and ethnic populations. Limited data regarding prevalence of AIH has estimated between 50 and 200 cases per 1 million among Caucasians from Western Europe and North America.
Explore Active Research Studies
Indiana University School of Medicine is actively conducting clinical research to advance the prevention, diagnosis, and treatment of liver, gastrointestinal, and pancreatic conditions. Patients, caregivers, and community members who are interested in learning more about current, open research studies are encouraged to explore our clinical studies database.
Participation in research is voluntary and may offer opportunities to contribute to medical advancements that improve patient care now and in the future.